-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
2
-
-
29244436366
-
Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases
-
Joosten J, Jager G, Oyen W, Wobbes T and Ruers T: Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. Eur J Surg Oncol 31: 1152-1159, 2005.
-
(2005)
Eur J Surg Oncol
, vol.31
, pp. 1152-1159
-
-
Joosten, J.1
Jager, G.2
Oyen, W.3
Wobbes, T.4
Ruers, T.5
-
3
-
-
58849099269
-
Surgical resection of a solitary pancreatic metastasis from colorectal cancer: A new step to a cure?
-
Gravalos C, García-Sanchez L, Hernandez M, Holgado E, Alvarez N, García-Escobar I, Martínez J and Robles L: Surgical resection of a solitary pancreatic metastasis from colorectal cancer: a new step to a cure? Clin Colorectal Cancer 7: 398-401, 2008.
-
(2008)
Clin Colorectal Cancer
, vol.7
, pp. 398-401
-
-
Gravalos, C.1
García-Sanchez, L.2
Hernandez, M.3
Holgado, E.4
Alvarez, N.5
García-Escobar, I.6
Martínez, J.7
Robles, L.8
-
4
-
-
58849115578
-
Trends in chemotherapy utilization for colorectal cancer
-
Renouf D, Kennecke H and Gill S: Trends in chemotherapy utilization for colorectal cancer. Clin Colorectal Cancer 7: 386-389, 2008.
-
(2008)
Clin Colorectal Cancer
, vol.7
, pp. 386-389
-
-
Renouf, D.1
Kennecke, H.2
Gill, S.3
-
5
-
-
2542615200
-
Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer
-
André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I and De Gramont A: Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351, 2004.
-
(2004)
N Engl J Med
, vol.350
, pp. 2343-2351
-
-
André, T.1
Boni, C.2
Mounedji-Boudiaf, L.3
Navarro, M.4
Tabernero, J.5
Hickish, T.6
Topham, C.7
Zaninelli, M.8
Clingan, P.9
Bridgewater, J.10
Tabah-Fisch, I.11
De Gramont, A.12
-
6
-
-
6044226542
-
Preoperative versus postoperative chemoradiotherapy for rectal cancer
-
Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H and Raab R: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740, 2004.
-
(2004)
N Engl J Med
, vol.351
, pp. 1731-1740
-
-
Sauer, R.1
Becker, H.2
Hohenberger, W.3
Rödel, C.4
Wittekind, C.5
Fietkau, R.6
Martus, P.7
Tschmelitsch, J.8
Hager, E.9
Hess, C.F.10
Karstens, J.H.11
Liersch, T.12
Schmidberger, H.13
Raab, R.14
-
7
-
-
36849078090
-
Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer
-
Zhang Y, Qin X, Zhang Y, Zhao L, Wang Y, Liu X and Yao L: Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer. J Cancer Res Clin Oncol 134: 219-226, 2008.
-
(2008)
J Cancer Res Clin Oncol
, vol.134
, pp. 219-226
-
-
Zhang, Y.1
Qin, X.2
Zhang, Y.3
Zhao, L.4
Wang, Y.5
Liu, X.6
Yao, L.7
-
8
-
-
48349097446
-
Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy
-
Hsu KF, Wu CL, Huang SC, Hsieh JL, Huang YS, Chen YF, Shen MR, Chung WJ, Chou CY and Shiau AL: Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy. Cancer Gene Ther 15: 526-534, 2008.
-
(2008)
Cancer Gene Ther
, vol.15
, pp. 526-534
-
-
Hsu, K.F.1
Wu, C.L.2
Huang, S.C.3
Hsieh, J.L.4
Huang, Y.S.5
Chen, Y.F.6
Shen, M.R.7
Chung, W.J.8
Chou, C.Y.9
Shiau, A.L.10
-
9
-
-
33644968334
-
An oncolytic adenovirus expressing soluble transforming growth factor-beta type II receptor for targeting breast cancer: In vitro evaluation
-
Wang ZG, Zhao W, Ramachandra M and Seth P: An oncolytic adenovirus expressing soluble transforming growth factor-beta type II receptor for targeting breast cancer: in vitro evaluation. Mol Cancer Ther 5: 367-373, 2006.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 367-373
-
-
Wang, Z.G.1
Zhao, W.2
Ramachandra, M.3
Seth, P.4
-
10
-
-
38649136288
-
Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma
-
Cui Q, Jiang W, Wang Y, Lv C, Luo J, Zhang W, Lin F, Yin Y, Cai R, Wei P and Qian C: Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma. Hepatology 47: 105-112, 2008.
-
(2008)
Hepatology
, vol.47
, pp. 105-112
-
-
Cui, Q.1
Jiang, W.2
Wang, Y.3
Lv, C.4
Luo, J.5
Zhang, W.6
Lin, F.7
Yin, Y.8
Cai, R.9
Wei, P.10
Qian, C.11
-
11
-
-
51449104765
-
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses
-
Kanerva A, Lavilla-Alonso S, Raki M, Kangasniemi L, Bauerschmitz GJ, Takayama K, Ristimäki A, Desmond RA and Hemminki A: Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses. PLoS One 3: e2917, 2008.
-
(2008)
PLoS One
, vol.3
-
-
Kanerva, A.1
Lavilla-Alonso, S.2
Raki, M.3
Kangasniemi, L.4
Bauerschmitz, G.J.5
Takayama, K.6
Ristimäki, A.7
Desmond, R.A.8
Hemminki, A.9
-
12
-
-
0033831080
-
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
-
Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK and Kirn DH: A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 6: 879-885, 2000.
-
(2000)
Nat Med
, vol.6
, pp. 879-885
-
-
Khuri, F.R.1
Nemunaitis, J.2
Ganly, I.3
Arseneau, J.4
Tannock, I.F.5
Romel, L.6
Gore, M.7
Ironside, J.8
MacDougall, R.H.9
Heise, C.10
Randlev, B.11
Gillenwater, A.M.12
Bruso, P.13
Kaye, S.B.14
Hong, W.K.15
Kirn, D.H.16
-
13
-
-
0030917202
-
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
-
Heise C, Sampson-Johannes A, Williams A, McCormick F, von Hoff DD and Kirn DH: ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med 3: 639-645, 1997.
-
(1997)
Nat Med
, vol.3
, pp. 639-645
-
-
Heise, C.1
Sampson-Johannes, A.2
Williams, A.3
McCormick, F.4
Von Hoff, D.D.5
Kirn, D.H.6
-
14
-
-
68149160020
-
Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo
-
Shen W, Wang CY, Wang XH and Fu ZX: Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 28: 81, 2009.
-
(2009)
J Exp Clin Cancer Res
, vol.28
, pp. 81
-
-
Shen, W.1
Wang, C.Y.2
Wang, X.H.3
Fu, Z.X.4
-
15
-
-
33947494918
-
Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis
-
Harrell MI, Iritani BM and Ruddell A: Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170: 774-786, 2007.
-
(2007)
Am J Pathol
, vol.170
, pp. 774-786
-
-
Harrell, M.I.1
Iritani, B.M.2
Ruddell, A.3
-
16
-
-
0036827801
-
Enzyme-activated prodrug therapy enhances tumor-specific replication of adenovirus vectors
-
Bernt KM, Steinwaerder DS, Ni S, Li ZY, Roffler SR and Lieber A: Enzyme-activated prodrug therapy enhances tumor-specific replication of adenovirus vectors. Cancer Res 62: 6089-6098, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 6089-6098
-
-
Bernt, K.M.1
Steinwaerder, D.S.2
Ni, S.3
Li, Z.Y.4
Roffler, S.R.5
Lieber, A.6
-
17
-
-
19744375006
-
Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models
-
Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC and Tanaka M: Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models. J Gene Med 7: 638-648, 2005.
-
(2005)
J Gene Med
, vol.7
, pp. 638-648
-
-
Nakano, K.1
Todo, T.2
Zhao, G.3
Yamaguchi, K.4
Kuroki, S.5
Cohen, J.B.6
Glorioso, J.C.7
Tanaka, M.8
-
18
-
-
41349099104
-
Cancer statistics, 2008
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
-
(2008)
CA Cancer J Clin
, vol.58
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Murray, T.6
Thun, M.J.7
-
19
-
-
0942266057
-
Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer
-
Miyachi K, Sasaki K, Onodera S, Taguchi T, Nagamachi M, Kaneko H and Sunagawa M: Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer, Gastric Cancer 6: 217-224, 2003.
-
(2003)
Gastric Cancer
, vol.6
, pp. 217-224
-
-
Miyachi, K.1
Sasaki, K.2
Onodera, S.3
Taguchi, T.4
Nagamachi, M.5
Kaneko, H.6
Sunagawa, M.7
-
20
-
-
55149107187
-
Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse
-
Yie SM, Lou B, Ye SR, Cao M, He X, Li P, Hu K, Rao L, Wu SM, Xiao HB and Gao E: Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 15: 3073-3082, 2008.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 3073-3082
-
-
Yie, S.M.1
Lou, B.2
Ye, S.R.3
Cao, M.4
He, X.5
Li, P.6
Hu, K.7
Rao, L.8
Wu, S.M.9
Xiao, H.B.10
Gao, E.11
-
21
-
-
70349787131
-
Significance of survivin, caspase-3 and VEGF expression in thyroid carcinoma
-
Zhang HY, Meng X, Du ZX, Fang CQ, Liu GL, Wang HQ and Deng WW: Significance of survivin, caspase-3 and VEGF expression in thyroid carcinoma. Clin Exp Med 9: 207-213, 2009.
-
(2009)
Clin Exp Med
, vol.9
, pp. 207-213
-
-
Zhang, H.Y.1
Meng, X.2
Du, Z.X.3
Fang, C.Q.4
Liu, G.L.5
Wang, H.Q.6
Deng, W.W.7
-
22
-
-
57649135364
-
Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA
-
Zheng JN, Pei DS, Mao LJ, Liu XY, Mei DD, Zhang BF, Shi Z, Wen RM and Sun XQ: Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. Cancer Gene Ther 16: 20-32, 2009.
-
(2009)
Cancer Gene Ther
, vol.16
, pp. 20-32
-
-
Zheng, J.N.1
Pei, D.S.2
Mao, L.J.3
Liu, X.Y.4
Mei, D.D.5
Zhang, B.F.6
Shi, Z.7
Wen, R.M.8
Sun, X.Q.9
-
23
-
-
65249112667
-
Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carring MDA-7/IL-24
-
Wu YM, Zhang KJ, Yue XT, Wang YQ, Yang Y, Li GC, Li N and Wang YG: Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carring MDA-7/IL-24. Acta Pharmacol Sin 30: 467-477, 2009.
-
(2009)
Acta Pharmacol Sin
, vol.30
, pp. 467-477
-
-
Wu, Y.M.1
Zhang, K.J.2
Yue, X.T.3
Wang, Y.Q.4
Yang, Y.5
Li, G.C.6
Li, N.7
Wang, Y.G.8
-
24
-
-
40949151900
-
Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil
-
Chu L, Gu J, Sun L, Qian Q, Qian C and Liu X: Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil. Gene Ther 15: 484-494, 2008.
-
(2008)
Gene Ther
, vol.15
, pp. 484-494
-
-
Chu, L.1
Gu, J.2
Sun, L.3
Qian, Q.4
Qian, C.5
Liu, X.6
-
25
-
-
4644293454
-
Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells
-
Carette JE, Overmeer RM, Schagen FH, Alemany R, Barski OA, Gerritsen WR and van Beusechem VW: Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells. Cancer Res 64: 2663-2667, 2004.
-
(2004)
Cancer Res
, vol.64
, pp. 2663-2667
-
-
Carette, J.E.1
Overmeer, R.M.2
Schagen, F.H.3
Alemany, R.4
Barski, O.A.5
Gerritsen, W.R.6
Van Beusechem, V.W.7
-
26
-
-
33646196844
-
Current strategies and future directions for eluding adenoviral vector immunity
-
Bangari DS and Mittal SK: Current strategies and future directions for eluding adenoviral vector immunity. Curr Gene Ther 6: 215-226, 2006.
-
(2006)
Curr Gene Ther
, vol.6
, pp. 215-226
-
-
Bangari, D.S.1
Mittal, S.K.2
-
27
-
-
17844388876
-
Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis
-
Wai PY, Mi Z, Guo H, Sarraf-Yazdi S, Gao C, Wei J, Marroquin CE, Clary B and Kuo PC: Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis. Carcinogenesis 26: 741-751, 2005.
-
(2005)
Carcinogenesis
, vol.26
, pp. 741-751
-
-
Wai, P.Y.1
Mi, Z.2
Guo, H.3
Sarraf-Yazdi, S.4
Gao, C.5
Wei, J.6
Marroquin, C.E.7
Clary, B.8
Kuo, P.C.9
-
28
-
-
62849100440
-
Imaging of lymph node micrometastases using an oncolytic herpes virus and [18F]FEAU PET
-
Brader P, Kelly K, Gang S, Shah JP, Wong RJ, Hricak H, Blasberg RG, Fong Y and Gil Z: Imaging of lymph node micrometastases using an oncolytic herpes virus and [18F]FEAU PET. PLoS One 4: e4789, 2009.
-
(2009)
PLoS One
, vol.4
-
-
Brader, P.1
Kelly, K.2
Gang, S.3
Shah, J.P.4
Wong, R.J.5
Hricak, H.6
Blasberg, R.G.7
Fong, Y.8
Gil, Z.9
|